Trichomoniasis: Genotype and Phenotype Correlations in African American Women
1 other identifier
observational
231
1 country
4
Brief Summary
The hypothesis to be tested in this trial is that the different epidemiologic (including racial differences) and phenotypic manifestations exhibited by Trichomonas clinical isolates during infection are correlated with their genotypic strain classification. Two specific aims are proposed to test that hypothesis. Specific aim 1. Assess the significance of genotypic or phenotypic differences in the Trichomonas strains among African American women by HIV status. Specific aim 2. Determine the significance of genotypic or phenotypic differences in the Trichomonas strains circulating among women from two different racial groups, African American women and Caucasian women. The overall goals of these specific aims are to identify racial differences in the genotypic and phenotypic characteristics of Trichomonas strains, and to develop the ability to identify and classify Trichomonas infections in order to prioritize treatment and epidemiologic follow-up of individuals infected with isolates associated with adverse clinical outcomes (HIV transmission or acquisition, pregnancy complications, virulence, or drug resistance).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2009
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 13, 2009
CompletedFirst Posted
Study publicly available on registry
October 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedMay 23, 2019
April 1, 2019
9.7 years
October 13, 2009
May 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of Trichomonas genotype with clinical symptoms, HIV status and patient race.
Trichomonas vaginalis isolates will be genotyped using Multilocus sequence typing (MLST) and the isolate genotypes will be assessed for correlations with clinical manifestations, drug resistance, HIV status, and demographic patient information.
Single visit
Study Arms (3)
African American HIV+
African American women with HIV and infected with Trichomonas
Caucasian HIV-
Caucasian women who are HIV negative and infected with Trichomonas
African American HIV-
African American women who are HIV negative and are infected with Trichomonas
Eligibility Criteria
Patients presenting to clinic sites with symptoms of a sexually transmitted disease
You may qualify if:
- Trichomonas infection
You may not qualify if:
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Women's Specialty Clinic at Mirror Lake
Flowood, Mississippi, 39232, United States
University Physicians Grants Ferry
Flowood, Mississippi, 39292, United States
Crossroads Clinics
Jackson, Mississippi, 39216, United States
University Physicians Jackson Medical Mall
Jackson, Mississippi, 39216, United States
Biospecimen
Trichomonas vaginalis clinical isolates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John C Meade, PhD
University of Mississippi Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2009
First Posted
October 20, 2009
Study Start
September 1, 2009
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
May 23, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will share
Data will be shared with other investigators upon completion of the study and journal acceptance of manuscripts detailing study results. Data may be accessed by contacting Dr. Meade